|
G |
Aco1 |
aconitase 1 |
decreases expression multiple interactions |
ISO |
lead nitrate results in decreased expression of ACO1 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead nitrate results in decreased expression of ACO1 protein] |
CTD |
PMID:22502979 |
|
NCBI chr 4:40,143,429...40,199,011
Ensembl chr 4:40,143,081...40,198,338
|
|
G |
Acta1 |
actin alpha 1, skeletal muscle |
increases expression |
EXP |
lead nitrate results in increased expression of ACTA1 protein |
CTD |
PMID:20435106 |
|
NCBI chr 8:124,618,497...124,621,514
Ensembl chr 8:124,618,508...124,621,490
|
|
G |
Ahr |
aryl-hydrocarbon receptor |
increases expression multiple interactions |
ISO |
lead nitrate results in increased expression of AHR mRNA; lead nitrate results in increased expression of AHR protein AHR promotes the reaction [lead nitrate results in decreased expression of GSTA1 mRNA]; AHR promotes the reaction [lead nitrate results in increased expression of TP53 mRNA] |
CTD |
PMID:31682781 |
|
NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
|
|
G |
Akap3 |
A kinase anchor protein 3 |
decreases expression |
ISO |
lead nitrate results in decreased expression of AKAP3 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 6:126,830,061...126,851,271
Ensembl chr 6:126,830,061...126,851,271
|
|
G |
Alad |
aminolevulinate, delta-, dehydratase |
decreases activity multiple interactions |
ISO |
lead nitrate results in decreased activity of ALAD protein lead nitrate inhibits the reaction [Dithiothreitol results in increased activity of ALAD protein]; lead nitrate inhibits the reaction [zinc chloride promotes the reaction [Dithiothreitol results in increased activity of ALAD protein]] |
CTD |
PMID:2061546 |
|
NCBI chr 4:62,422,762...62,438,300
Ensembl chr 4:62,427,406...62,438,155
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
decreases expression multiple interactions |
EXP |
lead nitrate results in decreased expression of APAF1 protein mangiferin inhibits the reaction [lead nitrate results in decreased expression of APAF1 protein] |
CTD |
PMID:23451106 |
|
NCBI chr10:90,825,173...90,918,688
Ensembl chr10:90,825,173...90,918,632
|
|
G |
Arhgdib |
Rho, GDP dissociation inhibitor beta |
increases expression |
EXP |
lead nitrate results in increased expression of ARHGDIB protein |
CTD |
PMID:20435106 |
|
NCBI chr 6:136,900,653...136,918,895
Ensembl chr 6:136,900,653...136,918,897
|
|
G |
Arrdc5 |
arrestin domain containing 5 |
decreases expression |
ISO |
lead nitrate results in decreased expression of ARRDC5 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr17:56,601,111...56,607,262
Ensembl chr17:56,601,111...56,607,286
|
|
G |
Azin2 |
antizyme inhibitor 2 |
decreases expression |
ISO |
lead nitrate results in decreased expression of AZIN2 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 4:128,824,026...128,856,250
Ensembl chr 4:128,824,026...128,856,235
|
|
G |
Bax |
BCL2-associated X protein |
multiple interactions increases expression |
EXP ISO |
mangiferin inhibits the reaction [lead nitrate results in increased expression of BAX protein] [lead nitrate results in increased abundance of Lead] which results in increased expression of BAX mRNA; titanium dioxide inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased expression of BAX mRNA]; titanium dioxide inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in increased expression of BAX mRNA] |
CTD |
PMID:23451106 PMID:30738203 |
|
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
decreases expression multiple interactions |
EXP ISO |
lead nitrate results in decreased expression of BCL2 protein mangiferin inhibits the reaction [lead nitrate results in decreased expression of BCL2 protein] [lead nitrate results in increased abundance of Lead] which results in decreased expression of BCL2 mRNA |
CTD |
PMID:23451106 PMID:30738203 |
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Casp3 |
caspase 3 |
increases expression multiple interactions increases activity |
EXP ISO |
lead nitrate results in increased expression of CASP3 protein mangiferin inhibits the reaction [lead nitrate results in increased expression of CASP3 protein] lead nitrate results in increased activity of CASP3 protein puerarin inhibits the reaction [lead nitrate results in increased activity of CASP3 protein] [lead nitrate results in increased abundance of Lead] which results in increased activity of CASP3 protein; [lead nitrate results in increased abundance of Lead] which results in increased expression of CASP3 mRNA; titanium dioxide inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in increased activity of CASP3 protein]; titanium dioxide inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in increased expression of CASP3 mRNA] |
CTD |
PMID:23451106 PMID:24505050 PMID:30738203 |
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Casp7 |
caspase 7 |
multiple interactions decreases expression |
EXP |
lead nitrate affects the reaction [CASP7 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [CASP7 affects the expression of MT2 mRNA] lead nitrate results in decreased expression of CASP7 mRNA |
CTD |
PMID:11891201 |
|
NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases expression |
EXP ISO |
mangiferin inhibits the reaction [lead nitrate results in increased expression of CASP9 protein] [lead nitrate results in increased abundance of Lead] which results in increased activity of CASP9 protein; [lead nitrate results in increased abundance of Lead] which results in increased expression of CASP9 mRNA; titanium dioxide inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in increased activity of CASP9 protein]; titanium dioxide inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in increased expression of CASP9 mRNA] |
CTD |
PMID:23451106 PMID:30738203 |
|
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
|
|
G |
Cat |
catalase |
decreases activity multiple interactions |
EXP ISO |
lead nitrate results in decreased activity of CAT protein mangiferin inhibits the reaction [lead nitrate results in decreased activity of CAT protein] Ashwagandha inhibits the reaction [lead nitrate results in decreased activity of CAT protein]; puerarin inhibits the reaction [lead nitrate results in decreased activity of CAT protein] [lead nitrate results in increased abundance of Lead] which results in decreased activity of CAT protein; titanium dioxide inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased activity of CAT protein] |
CTD |
PMID:23315276 PMID:23451106 PMID:24987671 PMID:30738203 |
|
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
|
|
G |
Ccng1 |
cyclin G1 |
multiple interactions |
EXP |
lead nitrate affects the reaction [CCNG1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [CCNG1 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr11:40,639,379...40,646,044
Ensembl chr11:40,639,379...40,646,138
|
|
G |
Cd86 |
CD86 antigen |
increases expression |
EXP |
lead nitrate results in increased expression of CD86 protein |
CTD |
PMID:23376802 |
|
NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443
|
|
G |
Cdyl |
chromodomain protein, Y chromosome-like |
decreases expression |
ISO |
lead nitrate results in decreased expression of CDYL mRNA |
CTD |
PMID:21628963 |
|
NCBI chr13:35,843,801...36,058,047
Ensembl chr13:35,843,816...36,058,046
|
|
G |
Chuk |
conserved helix-loop-helix ubiquitous kinase |
increases phosphorylation multiple interactions |
EXP |
lead nitrate results in increased phosphorylation of CHUK protein mangiferin inhibits the reaction [lead nitrate results in increased phosphorylation of CHUK protein] |
CTD |
PMID:23451106 |
|
NCBI chr19:44,061,773...44,095,940
Ensembl chr19:44,061,774...44,095,919
|
|
G |
Cox8c |
cytochrome c oxidase subunit 8C |
decreases expression |
ISO |
lead nitrate results in decreased expression of COX8C mRNA |
CTD |
PMID:21628963 |
|
NCBI chr12:102,865,565...102,866,793
Ensembl chr12:102,865,575...102,866,785
|
|
G |
Crisp2 |
cysteine-rich secretory protein 2 |
decreases expression |
ISO |
lead nitrate results in decreased expression of CRISP2 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr17:41,075,625...41,105,037
Ensembl chr17:41,074,911...41,117,894
|
|
G |
Cryaa |
crystallin, alpha A |
affects metabolic processing |
ISO |
lead nitrate affects the metabolism of CRYAA protein |
CTD |
PMID:21139692 |
|
NCBI chr17:31,896,905...31,900,704
Ensembl chr17:31,896,781...31,900,707
|
|
G |
Cryab |
crystallin, alpha B |
affects metabolic processing |
ISO |
lead nitrate affects the metabolism of CRYAB protein |
CTD |
PMID:21139692 |
|
NCBI chr 9:50,657,251...50,667,936
Ensembl chr 9:50,662,625...50,667,936
|
|
G |
Cst8 |
cystatin 8 (cystatin-related epididymal spermatogenic) |
decreases expression |
ISO |
lead nitrate results in decreased expression of CST8 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 2:148,640,759...148,647,516
Ensembl chr 2:148,640,705...148,647,515
|
|
G |
Ctnna1 |
catenin alpha 1 |
multiple interactions |
EXP |
lead nitrate affects the reaction [CTNNA1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [CTNNA1 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr18:35,251,955...35,387,829
Ensembl chr18:35,251,912...35,387,832
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions |
EXP ISO |
[lead nitrate results in increased abundance of Lead] which results in decreased expression of and affects the localization of CTNNB1 protein; [lead nitrate results in increased abundance of Lead] which results in decreased expression of CTNNB1 mRNA; icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased expression of and affects the localization of CTNNB1 protein]; icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased expression of CTNNB1 mRNA] lead nitrate inhibits the reaction [[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbate-2-phosphate] results in increased expression of CTNNB1 mRNA] |
CTD |
PMID:30731080 PMID:35738543 |
|
NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573
|
|
G |
Cux2 |
cut-like homeobox 2 |
multiple interactions |
EXP |
lead nitrate affects the reaction [CUX2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [CUX2 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 5:121,996,025...122,188,522
Ensembl chr 5:121,994,429...122,188,165
|
|
G |
Cxcl15 |
C-X-C motif chemokine ligand 15 |
increases expression |
ISO |
lead nitrate results in increased expression of CXCL8 protein |
CTD |
PMID:34189835 |
|
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases expression |
ISO |
lead nitrate inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A1 protein]; lead nitrate inhibits the reaction [benz(a)anthracene results in increased activity of CYP1A1 protein]; lead nitrate inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A1 protein]; lead nitrate inhibits the reaction [benzo(b)fluoranthene results in increased activity of CYP1A1 protein]; lead nitrate inhibits the reaction [benzo(k)fluoranthene results in increased activity of CYP1A1 protein]; lead nitrate inhibits the reaction [benzo(k)fluoranthene results in increased expression of CYP1A1 protein]; lead nitrate inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A1 protein]; lead nitrate promotes the reaction [benzo(k)fluoranthene results in increased expression of CYP1A1 protein]; Resveratrol inhibits the reaction [lead nitrate results in increased expression of CYP1A1 mRNA] lead nitrate results in increased expression of CYP1A1 mRNA; lead nitrate results in increased expression of CYP1A1 protein lead nitrate inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A1 protein]; lead nitrate inhibits the reaction [2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of CYP1A1 mRNA]; lead nitrate inhibits the reaction [2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of CYP1A1 protein]; lead nitrate inhibits the reaction [2-methoxy-4-aminoazobenzene results in increased expression of CYP1A1 protein]; lead nitrate inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 protein]; lead nitrate inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 protein]; lead nitrate inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 protein]; Resveratrol inhibits the reaction [lead nitrate results in increased expression of CYP1A1 mRNA] |
CTD |
PMID:8902619 PMID:11162773 PMID:11408366 PMID:17889500 PMID:23391631 PMID:31682781 More...
|
|
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
decreases activity multiple interactions |
ISO |
lead nitrate results in decreased activity of CYP1A2 protein lead nitrate inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A2 mRNA]; lead nitrate inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A2 protein]; lead nitrate inhibits the reaction [2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of CYP1A2 mRNA]; lead nitrate inhibits the reaction [2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of CYP1A2 protein]; lead nitrate inhibits the reaction [2-methoxy-4-aminoazobenzene results in increased expression of CYP1A2 mRNA]; lead nitrate inhibits the reaction [2-methoxy-4-aminoazobenzene results in increased expression of CYP1A2 protein]; lead nitrate inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein]; lead nitrate inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 protein]; lead nitrate inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A2 protein]; lead nitrate results in decreased expression of and results in decreased activity of CYP1A2 protein |
CTD |
PMID:8902619 PMID:11162773 |
|
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
|
|
G |
Cyp2c52-ps |
cytochrome P450, family 2, subfamily c, polypeptide 52, pseudogene |
increases expression |
ISO |
lead nitrate results in increased expression of CYP2C11 mRNA |
CTD |
PMID:23391631 |
|
NCBI chr19:38,965,106...38,992,071
Ensembl chr19:38,965,091...38,991,733
|
|
G |
Cyp4a12b |
cytochrome P450, family 4, subfamily a, polypeptide 12B |
increases expression |
ISO |
lead nitrate results in increased expression of CYP4A1 mRNA |
CTD |
PMID:23391631 |
|
NCBI chr 4:115,268,821...115,296,231
Ensembl chr 4:115,268,821...115,296,231
|
|
G |
Cyp51 |
cytochrome P450, family 51 |
increases expression multiple interactions |
EXP ISO |
lead nitrate results in increased expression of CYP51 mRNA [IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in increased expression of CYP51 mRNA] |
CTD |
PMID:15475176 PMID:22293356 |
|
NCBI chr 5:4,130,674...4,154,697
Ensembl chr 5:4,131,145...4,154,746
|
|
G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
decreases expression multiple interactions |
EXP ISO |
lead nitrate results in decreased expression of CYP7A1 mRNA [IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in decreased expression of CYP7A1 mRNA] |
CTD |
PMID:15475176 PMID:16049268 PMID:22293356 |
|
NCBI chr 4:6,265,612...6,275,632
Ensembl chr 4:6,265,612...6,275,633
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
lead nitrate results in increased expression of DDIT3 mRNA |
CTD |
PMID:14971657 |
|
NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157 Ensembl chr10:127,126,643...127,132,157
|
|
G |
Dkk1 |
dickkopf WNT signaling pathway inhibitor 1 |
multiple interactions |
EXP |
[lead nitrate results in increased abundance of Lead] which results in increased expression of DKK1 mRNA; [lead nitrate results in increased abundance of Lead] which results in increased expression of DKK1 protein; icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in increased expression of DKK1 mRNA]; icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in increased expression of DKK1 protein] |
CTD |
PMID:30731080 |
|
NCBI chr19:30,523,276...30,526,896
Ensembl chr19:30,523,263...30,527,065
|
|
G |
Dmp1 |
dentin matrix protein 1 |
multiple interactions |
ISO |
lead nitrate inhibits the reaction [[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbate-2-phosphate] results in increased expression of DMP1 mRNA] |
CTD |
PMID:35738543 |
|
NCBI chr 5:104,345,441...104,361,968
Ensembl chr 5:104,350,479...104,361,968
|
|
G |
Dnase1 |
deoxyribonuclease I |
multiple interactions |
EXP |
lead nitrate affects the reaction [DNASE1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [DNASE1 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr16:3,855,007...3,857,888
Ensembl chr16:3,854,806...3,857,888
|
|
G |
Dnmt3a |
DNA methyltransferase 3A |
multiple interactions decreases expression |
ISO |
4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead nitrate results in decreased expression of DNMT3A mRNA]; E2F1 protein inhibits the reaction [lead nitrate results in decreased expression of DNMT3A mRNA]; RTKI cpd inhibits the reaction [lead nitrate results in decreased expression of DNMT3A mRNA] lead nitrate results in decreased expression of DNMT3A mRNA; lead nitrate results in decreased expression of DNMT3A protein |
CTD |
PMID:24639330 |
|
NCBI chr12:3,851,559...3,964,442
Ensembl chr12:3,856,007...3,964,443
|
|
G |
Dspp |
dentin sialophosphoprotein |
multiple interactions |
ISO |
lead nitrate inhibits the reaction [[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbate-2-phosphate] results in increased expression of DSPP mRNA] |
CTD |
PMID:35738543 |
|
NCBI chr 5:104,318,569...104,327,993
Ensembl chr 5:104,318,578...104,327,993
|
|
G |
E2f1 |
E2F transcription factor 1 |
multiple interactions |
ISO |
E2F1 protein inhibits the reaction [lead nitrate results in decreased expression of DNMT3A mRNA]; E2F1 protein inhibits the reaction [lead nitrate results in increased expression of PTGS2 mRNA]; lead nitrate inhibits the reaction [E2F1 protein results in decreased expression of PTGS2 mRNA] |
CTD |
PMID:24639330 |
|
NCBI chr 2:154,401,320...154,411,812
Ensembl chr 2:154,401,327...154,411,812
|
|
G |
Egfl8 |
EGF-like domain 8 |
increases expression |
ISO |
lead nitrate results in increased expression of EGFL8 protein |
CTD |
PMID:19332663 |
|
NCBI chr17:34,832,174...34,835,536
Ensembl chr17:34,832,323...34,834,945
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions increases phosphorylation |
ISO |
EGFR mutant form affects the reaction [[lead nitrate results in increased expression of PLA2G4A mRNA] which results in increased secretion of Dinoprostone]; EGFR mutant form affects the reaction [lead nitrate results in increased expression of PLA2G4A mRNA]; EGFR mutant form affects the reaction [lead nitrate results in increased secretion of Dinoprostone]; EGFR promotes the reaction [lead nitrate results in increased expression of PLA2G4A mRNA]; RTKI cpd inhibits the reaction [lead nitrate results in increased phosphorylation of EGFR protein] |
CTD |
PMID:20850495 |
|
NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158
|
|
G |
Eif2ak1 |
eukaryotic translation initiation factor 2 alpha kinase 1 |
increases response to substance multiple interactions |
EXP |
EIF2AK1 gene mutant form results in increased susceptibility to lead nitrate [lead nitrate co-treated with EIF2AK1 gene mutant form] results in increased abundance of Bilirubin; [lead nitrate co-treated with EIF2AK1 gene mutant form] results in increased abundance of Malondialdehyde; [lead nitrate co-treated with EIF2AK1 gene mutant form] results in increased expression of HAMP mRNA |
CTD |
PMID:25411909 |
|
NCBI chr 5:143,803,586...143,839,535
Ensembl chr 5:143,803,543...143,841,069
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
increases phosphorylation multiple interactions |
ISO |
lead nitrate results in increased phosphorylation of EIF4EBP1 protein puerarin inhibits the reaction [lead nitrate results in increased phosphorylation of EIF4EBP1 protein] |
CTD |
PMID:27762461 |
|
NCBI chr 8:27,750,355...27,765,684
Ensembl chr 8:27,750,357...27,766,702
|
|
G |
Ercc1 |
excision repair cross-complementing rodent repair deficiency, complementation group 1 |
multiple interactions |
EXP |
lead nitrate affects the reaction [ERCC1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [ERCC1 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 7:19,079,016...19,090,449
Ensembl chr 7:19,078,703...19,090,449
|
|
G |
Ercc3 |
excision repair cross-complementing rodent repair deficiency, complementation group 3 |
multiple interactions |
EXP |
lead nitrate affects the reaction [ERCC3 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [ERCC3 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr18:32,373,357...32,403,206
Ensembl chr18:32,373,353...32,403,204
|
|
G |
Ezr |
ezrin |
multiple interactions |
EXP |
lead nitrate affects the reaction [EZR affects the expression of MT1 mRNA]; lead nitrate affects the reaction [EZR affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr17:7,005,530...7,050,179
Ensembl chr17:7,005,440...7,050,183
|
|
G |
Fabp9 |
fatty acid binding protein 9, testis |
decreases expression |
ISO |
lead nitrate results in decreased expression of FABP9 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 3:10,258,683...10,262,343
Ensembl chr 3:10,258,681...10,262,343
|
|
G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
increases expression |
ISO |
lead nitrate results in increased expression of FDFT1 mRNA |
CTD |
PMID:15475176 |
|
NCBI chr14:63,382,599...63,419,136
Ensembl chr14:63,382,599...63,417,027
|
|
G |
Fdps |
farnesyl diphosphate synthetase |
increases expression |
ISO |
lead nitrate results in increased expression of FDPS mRNA |
CTD |
PMID:15475176 |
|
NCBI chr 3:89,000,895...89,009,274
Ensembl chr 3:89,000,895...89,009,266
|
|
G |
Fhl1 |
four and a half LIM domains 1 |
decreases expression |
ISO |
lead nitrate results in decreased expression of FHL1 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr X:55,776,569...55,838,704
Ensembl chr X:55,777,147...55,838,706
|
|
G |
Fos |
FBJ osteosarcoma oncogene |
increases expression |
ISO |
lead nitrate results in increased expression of FOS mRNA |
CTD |
PMID:14971657 |
|
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
|
|
G |
Foxa2 |
forkhead box A2 |
multiple interactions |
EXP |
lead nitrate affects the reaction [FOXA2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [FOXA2 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 2:147,884,797...147,888,889
Ensembl chr 2:147,884,797...147,888,889
|
|
G |
Ftl1 |
ferritin light polypeptide 1 |
increases expression |
ISO |
lead nitrate results in increased expression of FTL protein |
CTD |
PMID:19332663 |
|
NCBI chr 7:45,107,368...45,109,310
Ensembl chr 7:45,107,368...45,109,308
|
|
G |
G6pdx |
glucose-6-phosphate dehydrogenase X-linked |
decreases activity |
ISO |
lead nitrate results in decreased activity of G6PD protein |
CTD |
PMID:28557068 |
|
NCBI chr X:73,453,089...73,472,486
Ensembl chr X:73,453,089...73,472,800
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible 45 alpha |
increases expression |
ISO |
lead nitrate results in increased expression of GADD45A mRNA |
CTD |
PMID:14971657 |
|
NCBI chr 6:67,012,080...67,014,391
Ensembl chr 6:67,012,080...67,014,441
|
|
G |
Garin1b |
golgi associated RAB2 interactor 1B |
decreases expression |
ISO |
lead nitrate results in decreased expression of GARIN1B mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 6:29,313,468...29,336,021
Ensembl chr 6:29,319,139...29,336,018
|
|
G |
Gfap |
glial fibrillary acidic protein |
multiple interactions increases expression |
ISO |
Ashwagandha inhibits the reaction [lead nitrate results in increased expression of GFAP mRNA]; Ashwagandha inhibits the reaction [lead nitrate results in increased expression of GFAP protein] lead nitrate results in increased expression of GFAP mRNA; lead nitrate results in increased expression of GFAP protein |
CTD |
PMID:24987671 |
|
NCBI chr11:102,778,162...102,791,368
Ensembl chr11:102,778,162...102,791,738
|
|
G |
Ggnbp1 |
gametogenetin binding protein 1 |
decreases expression |
ISO |
lead nitrate results in decreased expression of GGNBP1 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr17:27,237,009...27,255,352
Ensembl chr17:27,236,961...27,256,598
|
|
G |
Gh |
growth hormone |
multiple interactions decreases secretion |
ISO |
lead nitrate inhibits the reaction [GHRH protein results in increased expression of GH1 protein] lead nitrate results in decreased secretion of GH1 protein |
CTD |
PMID:12022635 |
|
NCBI chr11:106,191,087...106,194,529
Ensembl chr11:106,191,097...106,192,691
|
|
G |
Ghrh |
growth hormone releasing hormone |
multiple interactions |
ISO |
lead nitrate inhibits the reaction [GHRH protein results in increased expression of GH1 protein] |
CTD |
PMID:12022635 |
|
NCBI chr 2:157,171,416...157,190,645
Ensembl chr 2:157,171,417...157,189,426
|
|
G |
Gja5 |
gap junction protein, alpha 5 |
multiple interactions increases expression |
EXP |
lead nitrate affects the reaction [GJA5 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [GJA5 affects the expression of MT2 mRNA] lead nitrate results in increased expression of GJA5 mRNA |
CTD |
PMID:11891201 |
|
NCBI chr 3:96,939,718...96,960,950
Ensembl chr 3:96,812,009...96,984,732
|
|
G |
Gjb2 |
gap junction protein, beta 2 |
multiple interactions |
EXP |
lead nitrate affects the reaction [GJB2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [GJB2 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr14:57,336,059...57,342,159
Ensembl chr14:57,336,057...57,342,159
|
|
G |
Gm128 |
predicted gene 128 |
decreases expression |
ISO |
lead nitrate results in decreased expression of C2H1ORF56 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 3:95,144,230...95,148,946
Ensembl chr 3:95,144,231...95,148,909
|
|
G |
Grin2a |
glutamate receptor, ionotropic, NMDA2A (epsilon 1) |
multiple interactions |
EXP |
lead nitrate affects the reaction [GRIN2A affects the expression of MT1 mRNA]; lead nitrate affects the reaction [GRIN2A affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr16:9,385,765...9,813,744
Ensembl chr16:9,385,762...9,813,424
|
|
G |
Grin2c |
glutamate receptor, ionotropic, NMDA2C (epsilon 3) |
increases expression |
ISO |
lead nitrate results in increased expression of GRIN2C mRNA |
CTD |
PMID:23358146 |
|
NCBI chr11:115,139,995...115,158,123
Ensembl chr11:115,139,995...115,158,069
|
|
G |
Gsg1 |
germ cell associated 1 |
decreases expression |
ISO |
lead nitrate results in decreased expression of GSG1 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 6:135,214,327...135,231,334
Ensembl chr 6:135,214,324...135,231,349 Ensembl chr 6:135,214,324...135,231,349
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
multiple interactions |
EXP |
[lead nitrate results in increased abundance of Lead] which results in decreased phosphorylation of GSK3B protein; icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased phosphorylation of GSK3B protein] |
CTD |
PMID:30731080 |
|
NCBI chr16:37,909,363...38,066,446
Ensembl chr16:37,909,363...38,066,446
|
|
G |
Gsr |
glutathione reductase |
multiple interactions decreases activity |
EXP |
mangiferin inhibits the reaction [lead nitrate results in decreased activity of GSR protein] |
CTD |
PMID:23451106 |
|
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
|
|
G |
Gstt1 |
glutathione S-transferase, theta 1 |
multiple interactions |
EXP |
lead nitrate affects the reaction [GSTT1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [GSTT1 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
multiple interactions |
EXP |
[lead nitrate co-treated with EIF2AK1 gene mutant form] results in increased expression of HAMP mRNA |
CTD |
PMID:25411909 |
|
NCBI chr 7:30,641,793...30,643,454
Ensembl chr 7:30,641,793...30,643,457
|
|
G |
Hmgb4 |
high-mobility group box 4 |
decreases expression |
ISO |
lead nitrate results in decreased expression of HMGB4 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 4:128,154,005...128,154,688
Ensembl chr 4:128,154,005...128,154,750
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
increases expression multiple interactions |
EXP ISO |
lead nitrate results in increased expression of HMGCR mRNA [IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in increased expression of HMGCR mRNA] |
CTD |
PMID:15475176 PMID:16705668 PMID:22293356 |
|
NCBI chr13:96,785,470...96,807,444
Ensembl chr13:96,785,475...96,807,444
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO |
lead nitrate results in increased expression of HMOX1 mRNA |
CTD |
PMID:23391631 PMID:34189835 |
|
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
G |
Hnf4a |
hepatic nuclear factor 4, alpha |
decreases expression |
EXP |
lead nitrate results in decreased expression of HNF4A mRNA |
CTD |
PMID:16049268 |
|
NCBI chr 2:163,348,731...163,414,827
Ensembl chr 2:163,348,728...163,414,830
|
|
G |
Hsp90ab1 |
heat shock protein 90 alpha (cytosolic), class B member 1 |
multiple interactions |
EXP |
lead nitrate affects the reaction [HSP90AB1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [HSP90AB1 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr17:45,878,704...45,884,187
Ensembl chr17:45,878,701...45,884,197
|
|
G |
Hspa2 |
heat shock protein 2 |
multiple interactions increases expression decreases expression |
ISO |
Ashwagandha inhibits the reaction [lead nitrate results in increased expression of HSPA2 mRNA] lead nitrate results in decreased expression of HSPA2 mRNA |
CTD |
PMID:21628963 PMID:24987671 |
|
NCBI chr12:76,450,688...76,453,712
Ensembl chr12:76,450,950...76,453,712
|
|
G |
Hspa5 |
heat shock protein 5 |
increases expression |
EXP ISO |
lead nitrate results in increased expression of HSPA5 protein lead nitrate results in increased expression of HSPA5 mRNA |
CTD |
PMID:14971657 PMID:20435106 |
|
NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
|
|
G |
Hspa9 |
heat shock protein 9 |
multiple interactions increases expression |
ISO |
Ashwagandha inhibits the reaction [lead nitrate results in increased expression of HSPA9 mRNA]; Ashwagandha inhibits the reaction [lead nitrate results in increased expression of HSPA9 protein] lead nitrate results in increased expression of HSPA9 mRNA; lead nitrate results in increased expression of HSPA9 protein |
CTD |
PMID:24987671 |
|
NCBI chr18:35,070,467...35,087,404
Ensembl chr18:35,070,467...35,087,410
|
|
G |
Igf2 |
insulin-like growth factor 2 |
multiple interactions |
EXP |
lead nitrate affects the reaction [IGF2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [IGF2 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 7:142,204,505...142,220,566
Ensembl chr 7:142,204,503...142,220,553
|
|
G |
Igfbp6 |
insulin-like growth factor binding protein 6 |
multiple interactions |
EXP |
lead nitrate affects the reaction [IGFBP6 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [IGFBP6 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr15:102,052,621...102,057,947
Ensembl chr15:102,052,797...102,057,946
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions increases expression |
EXP |
[IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in decreased expression of CYP7A1 mRNA]; [IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in increased expression of CYP51 mRNA]; [IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in increased expression of HMGCR mRNA]; [IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in increased expression of TNF mRNA]; [IL1A gene mutant form co-treated with IL1B gene mutant form] results in decreased susceptibility to lead nitrate lead nitrate results in increased expression of IL1A mRNA |
CTD |
PMID:22293356 |
|
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases expression |
EXP ISO |
[IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in decreased expression of CYP7A1 mRNA]; [IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in increased expression of CYP51 mRNA]; [IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in increased expression of HMGCR mRNA]; [IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in increased expression of TNF mRNA]; [IL1A gene mutant form co-treated with IL1B gene mutant form] results in decreased susceptibility to lead nitrate lead nitrate results in increased expression of IL1B mRNA; lead nitrate results in increased expression of IL1B protein |
CTD |
PMID:15475176 PMID:16049268 PMID:22293356 |
|
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Il2 |
interleukin 2 |
decreases secretion |
ISO |
lead nitrate results in decreased secretion of IL2 protein |
CTD |
PMID:27714827 |
|
NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
|
|
G |
Il6ra |
interleukin 6 receptor, alpha |
multiple interactions |
EXP |
lead nitrate affects the reaction [IL6RA affects the expression of MT1 mRNA]; lead nitrate affects the reaction [IL6RA affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 3:89,776,631...89,820,503
Ensembl chr 3:89,771,366...89,820,503
|
|
G |
Ins1 |
insulin I |
multiple interactions |
EXP |
[lead nitrate results in increased abundance of Lead] inhibits the reaction [Glucose results in increased secretion of INS1 protein] |
CTD |
PMID:33038468 |
|
NCBI chr19:52,252,735...52,253,453
Ensembl chr19:52,252,735...52,253,914
|
|
G |
Iqcf1 |
IQ motif containing F1 |
decreases expression |
ISO |
lead nitrate results in decreased expression of IQCF1 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 9:106,377,166...106,379,449
Ensembl chr 9:106,377,166...106,379,453
|
|
G |
Iqcf5 |
IQ motif containing F5 |
decreases expression |
ISO |
lead nitrate results in decreased expression of IQCF5 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 9:106,391,772...106,393,202
Ensembl chr 9:106,391,772...106,393,209
|
|
G |
Itga6 |
integrin alpha 6 |
multiple interactions |
EXP |
lead nitrate affects the reaction [ITGA6 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [ITGA6 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 2:71,617,236...71,688,761
Ensembl chr 2:71,575,960...71,688,760
|
|
G |
Itgam |
integrin alpha M |
multiple interactions |
EXP |
lead nitrate affects the reaction [ITGAM affects the expression of MT1 mRNA]; lead nitrate affects the reaction [ITGAM affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 7:127,661,812...127,717,663
Ensembl chr 7:127,661,812...127,717,663
|
|
G |
Krt14 |
keratin 14 |
increases expression |
EXP |
lead nitrate results in increased expression of KRT14 protein |
CTD |
PMID:20435106 |
|
NCBI chr11:100,093,988...100,098,336
Ensembl chr11:100,093,988...100,098,374
|
|
G |
Lamp1 |
lysosomal-associated membrane protein 1 |
increases expression |
EXP |
lead nitrate results in increased expression of LAMP1 protein |
CTD |
PMID:23376802 |
|
NCBI chr 8:13,209,161...13,225,338
Ensembl chr 8:13,209,161...13,225,338
|
|
G |
Lamp2 |
lysosomal-associated membrane protein 2 |
increases expression |
EXP |
lead nitrate results in increased expression of LAMP2 protein |
CTD |
PMID:23376802 |
|
NCBI chr X:37,488,524...37,545,337
Ensembl chr X:37,490,234...37,545,331
|
|
G |
Ldhc |
lactate dehydrogenase C |
decreases expression |
ISO |
lead nitrate results in decreased expression of LDHC mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 7:46,510,687...46,527,571
Ensembl chr 7:46,510,627...46,527,566
|
|
G |
Lrrc46 |
leucine rich repeat containing 46 |
decreases expression |
ISO |
lead nitrate results in decreased expression of LRRC46 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr11:96,925,428...96,932,195
Ensembl chr11:96,925,428...96,932,233
|
|
G |
Lta |
lymphotoxin A |
multiple interactions |
EXP |
lead nitrate affects the reaction [LTA affects the expression of MT1 mRNA]; lead nitrate affects the reaction [LTA affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr17:35,422,141...35,424,568
Ensembl chr17:35,422,141...35,424,327
|
|
G |
Lypd4 |
Ly6/Plaur domain containing 4 |
decreases expression |
ISO |
lead nitrate results in decreased expression of LYPD4 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 7:24,564,044...24,569,180
Ensembl chr 7:24,564,045...24,569,366
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
multiple interactions increases phosphorylation |
ISO EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead nitrate results in increased phosphorylation of MAPK1 protein]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead nitrate results in increased phosphorylation of MAPK1 protein]; RTKI cpd inhibits the reaction [lead nitrate results in increased phosphorylation of MAPK1 protein] mangiferin inhibits the reaction [lead nitrate results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:20850495 PMID:22502979 PMID:23451106 |
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
multiple interactions increases phosphorylation |
ISO EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead nitrate results in increased phosphorylation of MAPK3 protein]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead nitrate results in increased phosphorylation of MAPK3 protein]; RTKI cpd inhibits the reaction [lead nitrate results in increased phosphorylation of MAPK3 protein] mangiferin inhibits the reaction [lead nitrate results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:20850495 PMID:22502979 PMID:23451106 |
|
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
|
|
G |
Marchf11 |
membrane associated ring-CH-type finger 11 |
decreases expression |
ISO |
lead nitrate results in decreased expression of MARCHF11 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr15:26,309,134...26,409,672
Ensembl chr15:26,309,134...26,409,662
|
|
G |
Mcl1 |
myeloid cell leukemia sequence 1 |
multiple interactions |
EXP |
lead nitrate affects the reaction [MCL1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [MCL1 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 3:95,564,017...95,583,553
Ensembl chr 3:95,566,099...95,570,487
|
|
G |
Met |
met proto-oncogene |
multiple interactions |
EXP |
lead nitrate affects the reaction [MET affects the expression of MT1 mRNA]; lead nitrate affects the reaction [MET affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 6:17,463,351...17,573,979
Ensembl chr 6:17,463,799...17,573,979
|
|
G |
Mgst1 |
microsomal glutathione S-transferase 1 |
multiple interactions |
EXP |
lead nitrate affects the reaction [MGST1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [MGST1 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 6:138,117,525...138,133,753
Ensembl chr 6:138,117,314...138,133,753
|
|
G |
Mir139 |
microRNA 139 |
increases expression |
ISO |
lead nitrate results in increased expression of MIR139 mRNA |
CTD |
PMID:35738543 |
|
NCBI chr 7:101,124,583...101,124,650
Ensembl chr 7:101,124,583...101,124,650
|
|
G |
Mir142 |
microRNA 142 |
increases expression |
ISO |
lead nitrate results in increased expression of MIR142 mRNA |
CTD |
PMID:35738543 |
|
NCBI chr11:87,647,690...87,647,753
Ensembl chr11:87,647,690...87,647,753
|
|
G |
Mroh2b |
maestro heat-like repeat family member 2B |
decreases expression |
ISO |
lead nitrate results in decreased expression of MROH2B mRNA |
CTD |
PMID:21628963 |
|
NCBI chr15:4,927,697...4,991,689
Ensembl chr15:4,928,219...4,991,687
|
|
G |
mt-Co1 |
cytochrome c oxidase I, mitochondrial |
multiple interactions decreases expression |
ISO |
puerarin inhibits the reaction [lead nitrate results in decreased expression of COX1 mRNA] |
CTD |
PMID:23315276 |
|
NCBI chr MT:5,328...6,872
Ensembl chr MT:5,328...6,872
|
|
G |
mt-Co2 |
cytochrome c oxidase II, mitochondrial |
multiple interactions decreases expression |
ISO |
puerarin inhibits the reaction [lead nitrate results in decreased expression of COX2 mRNA] |
CTD |
PMID:23315276 |
|
NCBI chr MT:7,013...7,696
Ensembl chr MT:7,013...7,696
|
|
G |
mt-Co3 |
cytochrome c oxidase III, mitochondrial |
multiple interactions decreases expression |
ISO |
puerarin inhibits the reaction [lead nitrate results in decreased expression of COX3 mRNA] |
CTD |
PMID:23315276 |
|
NCBI chr MT:8,607...9,390
Ensembl chr MT:8,607...9,390
|
|
G |
Mt1 |
metallothionein 1 |
affects localization multiple interactions increases expression decreases response to substance |
EXP |
lead nitrate affects the localization of MT1 protein lead nitrate affects the reaction [CASP7 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [CCNG1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [CTNNA1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [CUX2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [DNASE1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [ERCC1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [ERCC3 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [EZR affects the expression of MT1 mRNA]; lead nitrate affects the reaction [FOXA2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [GJA5 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [GJB2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [GRIN2A affects the expression of MT1 mRNA]; lead nitrate affects the reaction [GSTT1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [HSP90AB1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [IGF2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [IGFBP6 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [IL6RA affects the expression of MT1 mRNA]; lead nitrate affects the reaction [ITGA6 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [ITGAM affects the expression of MT1 mRNA]; lead nitrate affects the reaction [LTA affects the expression of MT1 mRNA]; lead nitrate affects the reaction [MCL1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [MET affects the expression of MT1 mRNA]; lead nitrate affects the reaction [MGST1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [MYC affects the expression of MT1 mRNA]; lead nitrate affects the reaction [NFKBIB affects the expression of MT1 mRNA]; lead nitrate affects the reaction [NUMB affects the expression of MT1 mRNA]; lead nitrate affects the reaction [PIAS2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [POLD1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [POU3F3 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [RAD23 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [RBL2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [RUNX1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [SERPINA1B affects the expression of MT1 mRNA]; lead nitrate affects the reaction [SOCS1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [SP3 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [SQSTM1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [SUMO1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TBX2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TNFRSF1A affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TNFRSF1B affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TRIM27 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TSG101 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TTF1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [WNT4 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [ZFHX3 affects the expression of MT1 mRNA]; MT1 protein promotes the reaction [lead nitrate results in increased expression of SNCA mRNA] lead nitrate results in increased expression of MT1 mRNA MT1 results in decreased susceptibility to lead nitrate |
CTD |
PMID:11891201 PMID:19542206 |
|
NCBI chr 8:94,905,214...94,906,955
Ensembl chr 8:94,905,710...94,906,955
|
|
G |
Mt2 |
metallothionein 2 |
multiple interactions decreases response to substance |
EXP |
lead nitrate affects the reaction [CASP7 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [CCNG1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [CTNNA1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [CUX2 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [DNASE1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [ERCC1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [ERCC3 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [EZR affects the expression of MT2 mRNA]; lead nitrate affects the reaction [FOXA2 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [GJA5 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [GJB2 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [GRIN2A affects the expression of MT2 mRNA]; lead nitrate affects the reaction [GSTT1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [HSP90AB1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [IGF2 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [IGFBP6 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [IL6RA affects the expression of MT2 mRNA]; lead nitrate affects the reaction [ITGA6 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [ITGAM affects the expression of MT2 mRNA]; lead nitrate affects the reaction [LTA affects the expression of MT2 mRNA]; lead nitrate affects the reaction [MCL1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [MET affects the expression of MT2 mRNA]; lead nitrate affects the reaction [MGST1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [MYC affects the expression of MT2 mRNA]; lead nitrate affects the reaction [NFKBIB affects the expression of MT2 mRNA]; lead nitrate affects the reaction [NUMB affects the expression of MT2 mRNA]; lead nitrate affects the reaction [PIAS2 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [POLD1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [POU3F3 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [RAD23 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [RBL2 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [RUNX1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [SERPINA1B affects the expression of MT2 mRNA]; lead nitrate affects the reaction [SOCS1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [SP3 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [SQSTM1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [SUMO1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [TBX2 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [TNFRSF1A affects the expression of MT2 mRNA]; lead nitrate affects the reaction [TNFRSF1B affects the expression of MT2 mRNA]; lead nitrate affects the reaction [TRIM27 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [TSG101 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [TTF1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [WNT4 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [ZFHX3 affects the expression of MT2 mRNA] MT2 results in decreased susceptibility to lead nitrate |
CTD |
PMID:11891201 |
|
NCBI chr 8:94,899,246...94,900,195
Ensembl chr 8:94,899,292...94,900,196
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
multiple interactions increases phosphorylation |
ISO |
puerarin inhibits the reaction [lead nitrate results in increased phosphorylation of MTOR protein] |
CTD |
PMID:27762461 |
|
NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
|
|
G |
Myc |
myelocytomatosis oncogene |
multiple interactions |
EXP |
lead nitrate affects the reaction [MYC affects the expression of MT1 mRNA]; lead nitrate affects the reaction [MYC affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
|
|
G |
Myh6 |
myosin, heavy polypeptide 6, cardiac muscle, alpha |
decreases expression |
ISO |
lead nitrate results in decreased expression of MYH6 protein |
CTD |
PMID:23391631 |
|
NCBI chr14:55,179,378...55,205,553
Ensembl chr14:55,179,378...55,204,384
|
|
G |
Myh7 |
myosin, heavy polypeptide 7, cardiac muscle, beta |
increases expression multiple interactions |
ISO |
lead nitrate results in increased expression of MYH7 mRNA; lead nitrate results in increased expression of MYH7 protein resveratrol inhibits the reaction [lead nitrate results in increased expression of MYH7 mRNA] |
CTD |
PMID:23391631 |
|
NCBI chr14:55,208,141...55,232,083
Ensembl chr14:55,208,141...55,232,083
|
|
G |
Ncam1 |
neural cell adhesion molecule 1 |
multiple interactions decreases expression |
ISO |
Ashwagandha inhibits the reaction [lead nitrate results in decreased expression of NCAM1 mRNA]; Ashwagandha inhibits the reaction [lead nitrate results in decreased expression of NCAM1 protein] lead nitrate results in decreased expression of NCAM1 mRNA; lead nitrate results in decreased expression of NCAM1 protein |
CTD |
PMID:24987671 |
|
NCBI chr 9:49,413,434...49,710,909
Ensembl chr 9:49,413,436...49,710,225
|
|
G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
decreases expression multiple interactions |
EXP |
lead nitrate results in decreased expression of NFKBIA protein mangiferin inhibits the reaction [lead nitrate results in decreased expression of NFKBIA protein] |
CTD |
PMID:23451106 |
|
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
|
|
G |
Nfkbib |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, beta |
multiple interactions |
EXP |
lead nitrate affects the reaction [NFKBIB affects the expression of MT1 mRNA]; lead nitrate affects the reaction [NFKBIB affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 7:28,457,676...28,466,069
Ensembl chr 7:28,457,676...28,466,937
|
|
G |
Nppb |
natriuretic peptide type B |
increases expression |
ISO |
lead nitrate results in increased expression of NPPB mRNA |
CTD |
PMID:23391631 |
|
NCBI chr 4:148,070,264...148,071,662
Ensembl chr 4:148,070,245...148,071,662
|
|
G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
increases expression |
ISO |
lead nitrate results in increased expression of NQO1 mRNA |
CTD |
PMID:23391631 |
|
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
decreases expression |
EXP ISO |
lead nitrate results in decreased expression of NR0B2 mRNA |
CTD |
PMID:15475176 PMID:16049268 |
|
NCBI chr 4:133,280,687...133,283,997
Ensembl chr 4:133,280,687...133,283,847
|
|
G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
decreases expression |
ISO |
lead nitrate results in decreased expression of NR1H3 mRNA |
CTD |
PMID:15475176 |
|
NCBI chr 2:91,014,406...91,033,189
Ensembl chr 2:91,014,406...91,033,179
|
|
G |
Nr5a2 |
nuclear receptor subfamily 5, group A, member 2 |
increases expression |
EXP |
lead nitrate results in increased expression of NR5A2 mRNA |
CTD |
PMID:16049268 |
|
NCBI chr 1:136,770,300...136,888,186
Ensembl chr 1:136,770,309...136,888,186
|
|
G |
Numb |
NUMB endocytic adaptor protein |
multiple interactions |
EXP |
lead nitrate affects the reaction [NUMB affects the expression of MT1 mRNA]; lead nitrate affects the reaction [NUMB affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr12:83,840,808...83,968,708
Ensembl chr12:83,840,808...83,968,708
|
|
G |
Odf1 |
outer dense fiber of sperm tails 1 |
decreases expression |
ISO |
lead nitrate results in decreased expression of ODF1 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr15:38,219,447...38,226,979
Ensembl chr15:38,219,447...38,226,979
|
|
G |
Oxct2a |
3-oxoacid CoA transferase 2A |
decreases expression |
ISO |
lead nitrate results in decreased expression of OXCT2A mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 4:123,215,668...123,217,472
Ensembl chr 4:123,215,668...123,217,427
|
|
G |
Paqr5 |
progestin and adipoQ receptor family member V |
decreases expression |
ISO |
lead nitrate results in decreased expression of PAQR5 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 9:61,861,020...61,934,085
Ensembl chr 9:61,860,763...61,934,138
|
|
G |
Pias2 |
protein inhibitor of activated STAT 2 |
multiple interactions |
EXP |
lead nitrate affects the reaction [PIAS2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [PIAS2 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr18:77,152,883...77,243,406
Ensembl chr18:77,152,904...77,241,496
|
|
G |
Pla2g4a |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
multiple interactions increases expression |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[lead nitrate results in increased expression of PLA2G4A mRNA] which results in increased secretion of Dinoprostone]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead nitrate results in increased expression of PLA2G4A mRNA]; 2-aminoethoxydiphenyl borate inhibits the reaction [lead nitrate results in increased expression of PLA2G4A mRNA]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [[lead nitrate results in increased expression of PLA2G4A mRNA] which results in increased secretion of Dinoprostone]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead nitrate results in increased expression of PLA2G4A mRNA]; [lead nitrate results in increased expression of PLA2G4A mRNA] which results in increased secretion of Dinoprostone; EGFR mutant form affects the reaction [[lead nitrate results in increased expression of PLA2G4A mRNA] which results in increased secretion of Dinoprostone]; EGFR mutant form affects the reaction [lead nitrate results in increased expression of PLA2G4A mRNA]; EGFR promotes the reaction [lead nitrate results in increased expression of PLA2G4A mRNA]; RTKI cpd inhibits the reaction [[lead nitrate results in increased expression of PLA2G4A mRNA] which results in increased secretion of Dinoprostone]; RTKI cpd inhibits the reaction [lead nitrate results in increased expression of PLA2G4A mRNA] |
CTD |
PMID:20850495 |
|
NCBI chr 1:149,705,369...149,837,041
Ensembl chr 1:149,705,369...149,837,041
|
|
G |
Pold1 |
polymerase (DNA directed), delta 1, catalytic subunit |
multiple interactions |
EXP |
lead nitrate affects the reaction [POLD1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [POLD1 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 7:44,182,168...44,198,239
Ensembl chr 7:44,182,170...44,198,273
|
|
G |
Pou3f3 |
POU domain, class 3, transcription factor 3 |
multiple interactions |
EXP |
lead nitrate affects the reaction [POU3F3 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [POU3F3 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 1:42,734,928...42,739,370
Ensembl chr 1:42,734,085...42,742,336
|
|
G |
Prm1 |
protamine 1 |
decreases expression |
ISO |
lead nitrate results in decreased expression of PRM1 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr16:10,614,196...10,614,687
Ensembl chr16:10,614,190...10,623,703
|
|
G |
Prm3 |
protamine 3 |
decreases expression |
ISO |
lead nitrate results in decreased expression of PRM3 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr16:10,608,372...10,608,778
Ensembl chr16:10,608,369...10,608,778
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[lead nitrate results in increased expression of PTGS2 mRNA] which results in increased secretion of Dinoprostone]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead nitrate results in increased expression of PTGS2 mRNA]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [lead nitrate results in increased expression of PTGS2 mRNA]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [[lead nitrate results in increased expression of PTGS2 mRNA] which results in increased secretion of Dinoprostone]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead nitrate results in increased expression of PTGS2 mRNA]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead nitrate results in increased expression of PTGS2 protein]; [lead nitrate results in increased expression of PTGS2 mRNA] which results in increased secretion of Dinoprostone; Decitabine promotes the reaction [lead nitrate results in increased expression of PTGS2 mRNA]; E2F1 protein inhibits the reaction [lead nitrate results in increased expression of PTGS2 mRNA]; lead nitrate inhibits the reaction [E2F1 protein results in decreased expression of PTGS2 mRNA]; lead nitrate promotes the reaction [RB1 protein results in increased expression of PTGS2 mRNA]; RB1 protein promotes the reaction [lead nitrate results in increased expression of PTGS2 mRNA]; RTKI cpd inhibits the reaction [[lead nitrate results in increased expression of PTGS2 mRNA] which results in increased secretion of Dinoprostone]; RTKI cpd inhibits the reaction [lead nitrate results in increased expression of PTGS2 mRNA]; RTKI cpd inhibits the reaction [lead nitrate results in increased expression of PTGS2 protein] lead nitrate results in increased expression of PTGS2 mRNA; lead nitrate results in increased expression of PTGS2 protein |
CTD |
PMID:20850495 PMID:21435385 PMID:24639330 |
|
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
multiple interactions increases expression |
ISO |
4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead nitrate results in increased expression of RB1 mRNA]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead nitrate results in increased expression of RB1 protein]; lead nitrate promotes the reaction [RB1 protein results in increased expression of PTGS2 mRNA]; RB1 protein promotes the reaction [lead nitrate results in increased expression of PTGS2 mRNA]; RTKI cpd inhibits the reaction [lead nitrate results in increased expression of RB1 mRNA]; RTKI cpd inhibits the reaction [lead nitrate results in increased expression of RB1 protein] |
CTD |
PMID:24639330 |
|
NCBI chr14:73,430,298...73,563,446
Ensembl chr14:73,421,113...73,563,262
|
|
G |
Rbl2 |
RB transcriptional corepressor like 2 |
multiple interactions |
EXP |
lead nitrate affects the reaction [RBL2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [RBL2 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 8:91,796,685...91,850,472
Ensembl chr 8:91,796,685...91,850,472
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
multiple interactions increases expression |
EXP ISO |
mangiferin inhibits the reaction [lead nitrate results in increased expression of RELA protein] RELA promotes the reaction [lead nitrate results in decreased expression of GSTA1 mRNA]; RELA promotes the reaction [lead nitrate results in increased expression of TP53 mRNA] lead nitrate results in increased expression of RELA mRNA; lead nitrate results in increased expression of RELA protein |
CTD |
PMID:23451106 PMID:31682781 |
|
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
|
|
G |
Ribc2 |
RIB43A domain with coiled-coils 2 |
decreases expression |
ISO |
lead nitrate results in decreased expression of RIBC2 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr15:85,016,261...85,028,771
Ensembl chr15:85,016,279...85,028,771
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
increases phosphorylation multiple interactions |
ISO |
lead nitrate results in increased phosphorylation of RPS6KB1 protein puerarin inhibits the reaction [lead nitrate results in increased phosphorylation of RPS6KB1 protein] |
CTD |
PMID:27762461 |
|
NCBI chr11:86,389,695...86,435,711
Ensembl chr11:86,389,697...86,435,631
|
|
G |
Runx1 |
runt related transcription factor 1 |
multiple interactions |
EXP |
lead nitrate affects the reaction [RUNX1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [RUNX1 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr16:92,398,354...92,622,962
Ensembl chr16:92,398,354...92,623,037
|
|
G |
Runx2 |
runt related transcription factor 2 |
multiple interactions |
EXP ISO |
[lead nitrate results in increased abundance of Lead] which results in decreased expression of RUNX2 mRNA; [lead nitrate results in increased abundance of Lead] which results in decreased expression of RUNX2 protein; icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased expression of RUNX2 mRNA]; icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased expression of RUNX2 protein] lead nitrate inhibits the reaction [[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbate-2-phosphate] results in increased expression of RUNX2 mRNA] |
CTD |
PMID:30731080 PMID:35738543 |
|
NCBI chr17:44,806,873...45,125,518
Ensembl chr17:44,806,874...45,125,684
|
|
G |
Serpina1b |
serine (or cysteine) preptidase inhibitor, clade A, member 1B |
multiple interactions |
EXP |
lead nitrate affects the reaction [SERPINA1B affects the expression of MT1 mRNA]; lead nitrate affects the reaction [SERPINA1B affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr12:103,694,415...103,704,448
Ensembl chr12:103,694,415...103,796,632
|
|
G |
Smcp |
sperm mitochondria-associated cysteine-rich protein |
decreases expression |
ISO |
lead nitrate results in decreased expression of SMCP mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 3:92,491,173...92,496,380
Ensembl chr 3:92,491,174...92,496,304
|
|
G |
Snca |
synuclein, alpha |
affects localization increases expression multiple interactions |
EXP |
lead nitrate affects the localization of SNCA protein lead nitrate results in increased expression of SNCA mRNA MT1 protein promotes the reaction [lead nitrate results in increased expression of SNCA mRNA] |
CTD |
PMID:19542206 |
|
NCBI chr 6:60,708,557...60,806,839
Ensembl chr 6:60,708,559...60,806,839
|
|
G |
Socs1 |
suppressor of cytokine signaling 1 |
multiple interactions |
EXP |
lead nitrate affects the reaction [SOCS1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [SOCS1 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr16:10,601,672...10,603,400
Ensembl chr16:10,600,104...10,603,400
|
|
G |
Sod1 |
superoxide dismutase 1, soluble |
multiple interactions decreases activity |
ISO |
Ashwagandha inhibits the reaction [lead nitrate results in decreased activity of SOD1 protein] |
CTD |
PMID:24987671 |
|
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
|
|
G |
Sp3 |
trans-acting transcription factor 3 |
multiple interactions decreases expression |
EXP |
lead nitrate affects the reaction [SP3 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [SP3 affects the expression of MT2 mRNA] lead nitrate results in decreased expression of SP3 mRNA |
CTD |
PMID:11891201 |
|
NCBI chr 2:72,766,774...72,810,790
Ensembl chr 2:72,766,771...72,810,790
|
|
G |
Spata18 |
spermatogenesis associated 18 |
decreases expression |
ISO |
lead nitrate results in decreased expression of SPATA18 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 5:73,808,723...73,836,927
Ensembl chr 5:73,808,722...73,836,855
|
|
G |
Spata20 |
spermatogenesis associated 20 |
decreases expression |
ISO |
lead nitrate results in decreased expression of SPATA20 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr11:94,369,730...94,376,136
Ensembl chr11:94,369,730...94,377,005
|
|
G |
Spata21 |
spermatogenesis associated 21 |
decreases expression |
ISO |
lead nitrate results in decreased expression of SPATA21 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 4:140,815,631...140,840,071
Ensembl chr 4:140,815,644...140,840,071
|
|
G |
Spata6 |
spermatogenesis associated 6 |
decreases expression |
ISO |
lead nitrate results in decreased expression of SPATA6 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 4:111,577,151...111,686,339
Ensembl chr 4:111,577,181...111,686,381
|
|
G |
Sqstm1 |
sequestosome 1 |
multiple interactions increases expression |
EXP ISO |
lead nitrate affects the reaction [SQSTM1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [SQSTM1 affects the expression of MT2 mRNA] lead nitrate results in increased expression of SQSTM1 protein puerarin inhibits the reaction [lead nitrate results in increased expression of SQSTM1 protein] |
CTD |
PMID:11891201 PMID:27762461 |
|
NCBI chr11:50,090,979...50,105,303
Ensembl chr11:50,090,193...50,101,654
|
|
G |
Srebf2 |
sterol regulatory element binding factor 2 |
increases expression |
ISO |
lead nitrate results in increased expression of SREBF2 mRNA |
CTD |
PMID:15475176 PMID:16705668 |
|
NCBI chr15:82,031,455...82,089,580
Ensembl chr15:82,031,382...82,089,580
|
|
G |
Sumo1 |
small ubiquitin-like modifier 1 |
multiple interactions |
EXP |
lead nitrate affects the reaction [SUMO1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [SUMO1 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 1:59,678,593...59,709,993
Ensembl chr 1:59,625,717...59,709,993
|
|
G |
Tbx2 |
T-box 2 |
multiple interactions |
EXP |
lead nitrate affects the reaction [TBX2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TBX2 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr11:85,723,441...85,732,774
Ensembl chr11:85,723,377...85,732,774
|
|
G |
Tekt2 |
tektin 2 |
decreases expression |
ISO |
lead nitrate results in decreased expression of TEKT2 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 4:126,215,914...126,219,481
Ensembl chr 4:126,215,914...126,219,481
|
|
G |
Tekt4 |
tektin 4 |
decreases expression |
ISO |
lead nitrate results in decreased expression of TEKT4 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr17:25,673,511...25,695,576
Ensembl chr17:25,673,515...25,695,576
|
|
G |
Tmod1 |
tropomodulin 1 |
decreases expression |
ISO |
lead nitrate results in decreased expression of TMOD1 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 4:46,038,940...46,116,032
Ensembl chr 4:46,038,935...46,116,032
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
EXP ISO |
[IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in increased expression of TNF mRNA] Lead nitrate increases expression of Tnf mRNA in liver |
CTD RGD |
PMID:15475176 PMID:16049268 PMID:22293356 PMID:7943184 PMID:9049203 |
RGD:14995476, RGD:14995487 |
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
multiple interactions |
EXP |
lead nitrate affects the reaction [TNFRSF1A affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TNFRSF1A affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
|
|
G |
Tnfrsf1b |
tumor necrosis factor receptor superfamily, member 1b |
multiple interactions |
EXP |
lead nitrate affects the reaction [TNFRSF1B affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TNFRSF1B affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 4:144,938,938...144,973,453
Ensembl chr 4:144,940,033...144,973,440
|
|
G |
Tnp1 |
transition protein 1 |
decreases expression |
ISO |
lead nitrate results in decreased expression of TNP1 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 1:73,054,233...73,055,058
Ensembl chr 1:73,054,233...73,055,068
|
|
G |
Tnp2 |
transition protein 2 |
decreases expression |
ISO |
lead nitrate results in decreased expression of TNP2 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr16:10,605,799...10,606,519
Ensembl chr16:10,605,800...10,606,524
|
|
G |
Tppp2 |
tubulin polymerization-promoting protein family member 2 |
decreases expression |
ISO |
lead nitrate results in decreased expression of TPPP2 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr14:52,155,887...52,158,161
Ensembl chr14:52,155,882...52,158,157
|
|
G |
Trim27 |
tripartite motif-containing 27 |
multiple interactions |
EXP |
lead nitrate affects the reaction [TRIM27 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TRIM27 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr13:21,363,570...21,378,893
Ensembl chr13:21,363,615...21,378,894
|
|
G |
Trp53 |
transformation related protein 53 |
multiple interactions increases expression |
ISO |
[lead nitrate results in increased abundance of Lead] which results in increased expression of TP53 mRNA; AHR promotes the reaction [lead nitrate results in increased expression of TP53 mRNA]; RELA promotes the reaction [lead nitrate results in increased expression of TP53 mRNA]; titanium dioxide inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in increased expression of TP53 mRNA] |
CTD |
PMID:30738203 PMID:31682781 |
|
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
|
|
G |
Trpm2 |
transient receptor potential cation channel, subfamily M, member 2 |
multiple interactions |
ISO |
lead nitrate inhibits the reaction [Adenosine Diphosphate Ribose results in increased activity of TRPM2 protein] |
CTD |
PMID:22750002 |
|
NCBI chr10:77,743,556...77,805,746
Ensembl chr10:77,743,556...77,806,397
|
|
G |
Tsc22d3 |
TSC22 domain family, member 3 |
multiple interactions |
EXP |
[lead nitrate results in increased abundance of Lead] inhibits the reaction [Hydrocortisone results in increased expression of TSC22D3 mRNA] |
CTD |
PMID:29957541 |
|
NCBI chr X:139,440,277...139,501,257
Ensembl chr X:139,440,277...139,501,408
|
|
G |
Tsg101 |
tumor susceptibility gene 101 |
multiple interactions |
EXP |
lead nitrate affects the reaction [TSG101 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TSG101 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 7:46,538,693...46,569,716
Ensembl chr 7:46,538,697...46,569,717
|
|
G |
Tssk2 |
testis-specific serine kinase 2 |
decreases expression |
ISO |
lead nitrate results in decreased expression of TSSK2 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr16:17,716,501...17,717,888
Ensembl chr16:17,716,501...17,717,888
|
|
G |
Tssk3 |
testis-specific serine kinase 3 |
decreases expression |
ISO |
lead nitrate results in decreased expression of TSSK3 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 4:129,382,801...129,385,523
Ensembl chr 4:129,382,807...129,384,815
|
|
G |
Ttf1 |
transcription termination factor, RNA polymerase I |
multiple interactions |
EXP |
lead nitrate affects the reaction [TTF1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TTF1 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 2:28,950,211...28,977,668
Ensembl chr 2:28,950,274...28,977,668
|
|
G |
Tuba8 |
tubulin, alpha 8 |
decreases expression |
ISO |
lead nitrate results in decreased expression of TUBA8 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 6:121,187,666...121,209,304
Ensembl chr 6:121,187,655...121,203,813
|
|
G |
Tulp2 |
TUB like protein 2 |
decreases expression |
ISO |
lead nitrate results in decreased expression of TULP2 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr 7:45,131,450...45,173,070
Ensembl chr 7:45,131,301...45,173,056
|
|
G |
Wnt1 |
wingless-type MMTV integration site family, member 1 |
multiple interactions |
ISO |
lead nitrate inhibits the reaction [[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbate-2-phosphate] results in increased expression of WNT1 mRNA] |
CTD |
PMID:35738543 |
|
NCBI chr15:98,687,738...98,691,711
Ensembl chr15:98,687,738...98,691,718
|
|
G |
Wnt3a |
wingless-type MMTV integration site family, member 3A |
multiple interactions |
EXP |
[lead nitrate results in increased abundance of Lead] which results in decreased expression of WNT3A mRNA; [lead nitrate results in increased abundance of Lead] which results in decreased expression of WNT3A protein; icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased expression of WNT3A mRNA]; icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased expression of WNT3A protein] |
CTD |
PMID:30731080 |
|
NCBI chr11:59,138,859...59,181,579
Ensembl chr11:59,138,859...59,181,578
|
|
G |
Wnt4 |
wingless-type MMTV integration site family, member 4 |
multiple interactions |
EXP |
lead nitrate affects the reaction [WNT4 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [WNT4 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 4:137,004,946...137,026,812
Ensembl chr 4:137,004,800...137,027,037
|
|
G |
Zfhx3 |
zinc finger homeobox 3 |
multiple interactions |
EXP |
lead nitrate affects the reaction [ZFHX3 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [ZFHX3 affects the expression of MT2 mRNA] |
CTD |
PMID:11891201 |
|
NCBI chr 8:109,005,975...109,688,272
Ensembl chr 8:108,669,276...109,688,262
|
|
G |
Znrf4 |
zinc and ring finger 4 |
decreases expression |
ISO |
lead nitrate results in decreased expression of ZNRF4 mRNA |
CTD |
PMID:21628963 |
|
NCBI chr17:56,818,248...56,819,483
Ensembl chr17:56,818,248...56,819,431
|
|